(Q76887710)

English

THE USE OF THE SERIAL THROMBIN TIME IN EVALUATING THERAPY WITH EPSILON AMINOCAPROIC ACID IN MASSIVE THROMBOLYSIS AND PROTEOLYSIS

scientific article published on 01 June 1964

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

14183048

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14183048%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 November 2019

title

THE USE OF THE SERIAL THROMBIN TIME IN EVALUATING THERAPY WITH EPSILON AMINOCAPROIC ACID IN MASSIVE THROMBOLYSIS AND PROTEOLYSIS (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

14183048

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14183048%20AND%20SRC:MED&resulttype=core&format=json

30 November 2019

1 reference

1 reference

I BRODSKY

1

1 reference

stated in

Europe PubMed Central

PubMed ID

14183048

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14183048%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 November 2019

E ROSS

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

14183048

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14183048%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 November 2019

W O REID

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed ID

14183048

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14183048%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 November 2019

language of work or name

English

0 references

publication date

1 June 1964

1 reference

stated in

Europe PubMed Central

PubMed ID

14183048

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14183048%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 November 2019

published in

American Journal of Clinical Pathology

1 reference

stated in

Europe PubMed Central

PubMed ID

14183048

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14183048%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 November 2019

volume

41

1 reference

stated in

Europe PubMed Central

PubMed ID

14183048

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14183048%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 November 2019

page(s)

589-596

1 reference

stated in

Europe PubMed Central

PubMed ID

14183048

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14183048%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 November 2019

Identifiers

DOI

10.1093/AJCP/41.6.589

1 reference

stated in

Europe PubMed Central

PubMed ID

14183048

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14183048%20AND%20SRC:MED&resulttype=core&format=json

30 November 2019

1 reference

Europe PubMed Central

PubMed ID

14183048

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14183048%20AND%20SRC:MED&resulttype=core&format=json

(Q76887710)

THE USE OF THE SERIAL THROMBIN TIME IN EVALUATING THERAPY WITH EPSILON AMINOCAPROIC ACID IN MASSIVE THROMBOLYSIS AND PROTEOLYSIS

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)